Company Overview

Update
Founded:
1982
Headquarters:
Rolling Meadows
IPO:
Went Public on Aug 13, 2008
Stock:
MYRG
Categories:
Construction
Description:
MYR is a biotechnology company developing drugs for the treatment of chronic hepatitis B and D infections.

Detailed Description

Update

MYR GmbH is a Burgwedel (Hannover), Germany-based biotech company that develops a drug for the treatment of chronic hepatitis B and D infections.

Current Team (2)

Update

Funding Rounds (1) - $707.7k

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Headquarters

    1701 Golf Road

    Suite 3-1012

    Rolling Meadows, 60008-4270